PARMAXPHARMALTD logo

Parmax Pharma Ltd

PARMAXPHARMALTD·NSE·
0.00 +0.00 (+0.00%)
Market Cap48.60 Cr
PE Ratio
Volume
Day High - Low
52W High-Low129.90 - 22.60
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
1.1/10
Poor
Fair Value
Sign in to see
ROE
105.30%
Strong
P/E
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals & Biotechnology
Overall View
Poor

Price performance

52W22.60
129.90
DocStoX take

Held back by growth (0.0). Scored on 3 of 5 measures.

DocStoX score

Low confidence
1.1
/10
Poor
Quality
Weak
ROE 105.3%
Valuation
No data
No valuation multiples
Growth
Flat
Revenue -14.3% 5Y CAGR
Risk
Elevated
D/E 0.00
Momentum
No data
No technical indicators

Scored on 3 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹49 Cr
52W High / Low
₹130 / ₹23
Dividend Yield
0.00%
Promoter Holding
30.80%
EPS (TTM)
₹-5.59
Book Value

Key highlights

  • Strong returns on equity (105%)
  • Low leverage — D/E 0.00
  • Revenue shrinking 14% a year
  • Loss-making in some of the last 5 years
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals & Biotechnology

Parmax Pharma Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.